Oxymetazoline Nasal Spray and Breastfeeding

No research has been done on breastfeeding and oxymetazoline nasal spray, so it is not known if this medication passes through breast milk in humans. Although a nasal spray decongestant likely would be safer than an oral decongestant, there is not enough research to support this claim. If you are breastfeeding, talk to your healthcare provider before using oxymetazoline nasal spray.

Is Oxymetazoline Nasal Spray Safe for Breastfeeding Women?

Oxymetazoline nasal spray (Afrin®, Nostrilla®, Sudafed OM™, and many others) is a non-prescription decongestant nasal spray. It is used for the treatment of nasal congestion due to allergies, the common cold, or other problems. Currently, it is unknown if oxymetazoline nasal spray passes through breast milk in humans. Therefore, if you are breastfeeding, you should talk with your healthcare provider before using this drug.
 

Breastfeeding and Oxymetazoline Nasal Spray: What Does the Research Say?

No studies have been done to see if oxymetazoline (the active ingredient in the nasal spray) passes through breast milk in humans. It makes sense that it would be safer to use a nasal spray decongestant rather than one that is taken by mouth, as less of the medication reaches the bloodstream when used as a nasal spray. However, more research is necessary to confirm this assumption.
 

Talking With Your Healthcare Provider

You should talk with your healthcare provider about breastfeeding and oxymetazoline nasal spray.
 Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
 
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation